Neurocrine Biosciences (NBIX) Other non-cash items (2010 - 2026)
Neurocrine Biosciences' Other non-cash items was $7.3 million in Q3 2026, up 10.6% from $6.6 million a year earlier and up 87.2% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Other non-cash items (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neurocrine Biosciences' Other non-cash items was $19.8 million through Sep 30, 2026, down 27.7% year-over-year; for FY2025, it was $26.8 million, up 157.7% from FY2024.
- Other non-cash items shows a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- In earlier years, Other non-cash items was $10.4 million in FY2024, -$900,000 in FY2023 and $70 million in FY2022.
- The Q3 2026 figure marks the highest quarterly Other non-cash items since Q2 2022.
- Compared with a year earlier, Other non-cash items was higher in 1 of the last four quarters, with an average decline of 26.5%.
- Per Business Quant data, NBIX's Other non-cash items in the three quarters before Q3 2026 was $3.9 million (Q2 2026), $2.7 million (Q1 2026) and $5.9 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.30 Mn |
| Jun 30, 2026 | 3.90 Mn |
| Mar 31, 2026 | 2.70 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 7.10 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 6.50 Mn |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 10.70 Mn |
| Mar 31, 2024 | -7.10 Mn |
| Dec 31, 2023 | -900,000.00 |
| Jun 30, 2022 | 70.00 Mn |
| Sep 30, 2011 | -9.24 Mn |
| Sep 30, 2010 | 772,000.00 |
API Access
Neurocrine Biosciences Other non-cash items API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-cash-items", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();